Author:
Nickel Kathrin,Menke Mia,Endres Dominique,Runge Kimon,Tucci Sara,Schumann Anke,Domschke Katharina,van Elst Ludger Tebartz,Maier Simon
Abstract
AbstractBackgroundPrevious research suggests potential mitochondrial dysfunction and changes in fatty acid metabolism in a subgroup of individuals with autism spectrum disorder (ASD), indicated by higher lactate, pyruvate levels, and mitochondrial disorder prevalence. This study aimed to further investigate potential mitochondrial dysfunction in ASD by assessing blood metabolite levels linked to mitochondrial metabolism.MethodsBlood levels of creatine kinase (CK), alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate, pyruvate, free and total carnitine, as well as acylcarnitines were obtained in 73 adults with ASD (47 males, 26 females) and compared with those of 71 neurotypical controls (NTC) (44 males, 27 females). Correlations between blood parameters and psychometric ASD symptom scores were also explored.ResultsElevated ALT (p = 0.024) and lower CK (p = 0.007) levels were found exclusively in males with ASD compared to NTC, with no such variation in females. AST levels were consistent in both groups. After correction for antipsychotic and antidepressant medication, only CK remained significant. ASD participants had lower serum lactate levels (p = 0.012) compared to NTC, but pyruvate and carnitine concentrations showed no significant difference. ASD subjects had significantly increased levels of certain acylcarnitines, with a decrease in tetradecadienoyl-carnitine (C14:2), and certain acylcarnitines correlated significantly with autistic symptom scores.DiscussionWe found reduced serum lactate levels in ASD, in contrast to previous studies suggesting elevated lactate or pyruvate. This difference may reflect the focus of our study on high-functioning adults with ASD, who are likely to have fewer secondary genetic conditions associated with mitochondrial dysfunction. Our findings of significantly altered acylcarnitine levels in ASD support the hypothesis of altered fatty acid metabolism in a subset of ASD patients.
Publisher
Cold Spring Harbor Laboratory